Peter Conlon Selected Research

Peter Conlon Research Topics

Disease

3	Skin Neoplasms (Skin Cancer) 07/2007 - 08/2005
2	Fatigue 11/2023 - 11/2019
2	Renal Insufficiency (Renal Failure) 01/2019 - 01/2018
2	Interstitial Nephritis (Tubulointerstitial Nephritis) 04/2018 - 11/2004
2	Neoplasms (Cancer) 05/2015 - 07/2007
1	Parkinson Disease (Parkinson's Disease) 12/2023
1	Rare Diseases (Rare Disease) 12/2023
1	Long QT Syndrome 12/2023
1	Cystic Kidney Diseases (Cystic Kidney Disease) 12/2023
1	Short Qt Syndrome 12/2023
1	Tremor (Tremors) 12/2023
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 12/2023
1	Epilepsy (Aura) 12/2023
1	Seizures (Absence Seizure) 12/2023
1	Glucose Intolerance 12/2023
1	COVID-19 11/2023
1	Hypersensitivity (Allergy) 04/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2023
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2023
1	Cysts 01/2021
1	Restless Legs Syndrome (Restless Legs) 11/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2018
1	Sclerosis 01/2018
1	Kidney Diseases (Kidney Disease) 01/2018
1	Mood Disorders (Mood Disorder) 01/2017
1	Mental Disorders (Mental Disorder) 01/2017
1	Schizophrenia (Dementia Praecox) 01/2017
1	Joint Instability (Joint Laxity) 02/2016
1	Delayed Graft Function 05/2015
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2013
1	Segmental glomerulosclerosis 01/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2007
1	Retinoblastoma (Glioblastoma, Retinal) 04/2007
1	Carcinogenesis 08/2005
1	Hemolytic-Uremic Syndrome 12/2002
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 07/2002
1	Inflammation (Inflammations) 07/2002

Drug/Important Bio-Agent (IBA)

1	Proteins (Proteins, Gene)FDA Link 12/2023
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 12/2023
1	Cisplatin (Platino)FDA LinkGeneric 04/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2023
1	Prednisolone (Predate)FDA LinkGeneric 01/2023
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2023
1	daratumumabIBA 01/2019
1	Adalimumab (Humira)FDA Link 04/2018
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2018
1	TenascinIBA 02/2016
1	Cytochrome P-450 CYP3AIBA 05/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2015
1	ForminsIBA 01/2012
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2007
1	Vitamin D FDA LinkGeneric 07/2007
1	VitaminsIBA 07/2007
1	Calcitriol Receptors (Calcitriol Receptor)IBA 07/2007
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 07/2007
1	Glutathione Transferase (Glutathione S-Transferase)IBA 04/2007
1	Interleukin-10 (Interleukin 10)IBA 04/2007
1	Sunscreening Agents (Sunscreens)IBA 08/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2004
1	Antigen-Antibody Complex (Immune Complex)IBA 07/2002

Therapy/Procedure

5	Transplantation 01/2018 - 08/2005
3	Kidney Transplantation 01/2017 - 12/2002
2	Therapeutics 04/2018 - 11/2004
2	Organ Transplantation 01/2017 - 07/2007
1	Occupational Therapy (Therapy, Occupational) 11/2023
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021
1	Peritoneal Dialysis 11/2019